Format

Send to

Choose Destination
See comment in PubMed Commons below

Overcoming Challenges to Develop Countermeasures Against Aerosolized Bioterrorism Agents: Appropriate Use of Animal Models.

Editors

National Research Council (US) Committee on Animal Models for Testing Interventions Against Aerosolized Bioterrorism Agents.

Source

Washington (DC): National Academies Press (US); 2006.
The National Academies Collection: Reports funded by National Institutes of Health.

Excerpt

An integral part of the development of new vaccines and therapeutics is obtaining the necessary approvals from the U.S. Food and Drug Administration both for their initial use in people and their eventual licensure for general use. The present accelerated pace of development, however, has led to several additional needs: standardization of methods for the generation and characterization of aerosols of bioterrorism agents for use in animal studies (necessary for licensure of vaccines and therapeutics), characterization of the threat to the population, and expansion of the number of laboratories conducting the research. The Committee on Animal Models for Testing Interventions Against Aerosolized Bioterrorism Agents was convened by the National Research Council to address these issues. It was tasked by its sponsor, the National Institute of Allergy and Infectious Disease, to prepare a short consensus report that articulates the difficulties of testing countermeasures to aerosolized bioterrorism agents and considers whether there are opportunities for improving current approaches to animal testing of countermeasures against aerosols by applying knowledge from other fields of science.

Copyright © 2006, National Academy of Sciences.

PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons
    Write to the Help Desk